AN2 Therapeutics, Inc.ANTXNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank50
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-38.11M
Near historical average
Percentile
P50
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-37.78M
Historical baseline
PeriodValueYoY Change
TTM$-38.11M+30.1%
2024$-54.55M+21.7%
2023$-69.64M-64.8%
2022$-42.26M-95.9%
2021$-21.57M-196.2%
2020$-7.28M+76.6%
2019$-31.07M-